Financials
- Market Capitalization 462.87 M
- Employee 23
- Founded 2014
- CEO N/A
- Website www.ovidrx.com
- Headquarter Delaware, United States
- FIGI BBG009F0TD76
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-10.57
Relación precio/flujo de caja
22.24
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2963 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.64 USD | -1.55% | +5.96% | +20.70% | -20.42% | 471.78 M USD | ||
| 2965 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.56 USD | +0.65% | -17.89% | -6.02% | -25.00% | 471.21 M USD | ||
| 2987 | SLN Silence Therapeutics Plc - American Depository Share | 9.69 USD | -0.62% | -3.68% | +43.56% | +49.77% | 457.70 M USD | ||
| 2988 | RZLT Rezolute, Inc. - Common Stock | 4.75 USD | -1.66% | -4.43% | +9.20% | -6.86% | 457.39 M USD |